Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists

The thrombopoietin receptor agonists (TPO-RAs) romiplostim, eltrombopag, avatrombopag, and lusutrombopag carry unique US Food and Drug Administration (US FDA)- and European Medicines Agency (EMA)-approved indications and may be used to increase platelet counts in a variety of conditions. Current ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilreath, Jeffrey, Lo, Mimi, Bubalo, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318934/
https://www.ncbi.nlm.nih.gov/pubmed/34160821
http://dx.doi.org/10.1007/s40265-021-01553-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318934/
https://www.ncbi.nlm.nih.gov/pubmed/34160821
http://dx.doi.org/10.1007/s40265-021-01553-7

Ejemplares similares